Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study
dc.contributor.author
dc.date.accessioned
2022-09-01T08:59:03Z
dc.date.available
2022-09-01T08:59:03Z
dc.date.issued
2022-05-17
dc.identifier.uri
dc.description.abstract
Letter to the editor about the validation and functional characterization of identified GWAS variants for chronic lymphocytic leukemia
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Springer Nature
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.1038/s41408-022-00676-8
dc.relation.ispartof
Blood Cancer Journal, 2022, vol. 12, art.núm. 79
dc.relation.ispartofseries
Articles publicats (D-I)
dc.rights
Attribution 4.0 International
dc.rights.uri
dc.title
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
035417
dc.type.peerreviewed
peer-reviewed
dc.identifier.eissn
2044-5385